AKT1 and nasopharyngeal carcinoma: To understand the role of AKT in EMT and its association with radioresistance in NPC, a pan-AKT kinase inhibitor currently in clinical development for patients with various malignancies (16) was used to prevent the activation of AKT following radiation.